摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1'-bromo-2',3',4'-trimethoxybenzo[5',6':4,5]-1H-(aR,1S)-1-acetamido-6,7-dihydrocyclohepta[3, 4-f]-1H-2-hydroxymethylindole

中文名称
——
中文别名
——
英文名称
1'-bromo-2',3',4'-trimethoxybenzo[5',6':4,5]-1H-(aR,1S)-1-acetamido-6,7-dihydrocyclohepta[3, 4-f]-1H-2-hydroxymethylindole
英文别名
N-[(10S)-6-bromo-15-(hydroxymethyl)-3,4,5-trimethoxy-14-azatetracyclo[9.7.0.02,7.013,17]octadeca-1(11),2(7),3,5,12,15,17-heptaen-10-yl]acetamide
1'-bromo-2',3',4'-trimethoxybenzo[5',6':4,5]-1H-(aR,1S)-1-acetamido-6,7-dihydrocyclohepta[3, 4-f]-1H-2-hydroxymethylindole化学式
CAS
——
化学式
C23H25BrN2O5
mdl
——
分子量
489.366
InChiKey
XSJCIXPQXBYXIV-KRWDZBQOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    31
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    92.8
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of Nonracemic Pyrrolo-allocolchicinoids Exhibiting Potent Cytotoxic Activity
    作者:Ekaterina S. Shchegravina、Dmitry I. Knyazev、Irina P. Beletskaya、Elena V. Svirshchevskaya、Hans-Günther Schmalz、Alexey Yu. Fedorov
    DOI:10.1002/ejoc.201601069
    日期:2016.12
    An efficient eight-step semisynthetic approach towards nonracemic pyrrolo-allocolchicinoids starting from natural colchicine was developed by exploiting Pd-catalyzed domino Sonogashira coupling/5-endo-dig cyclization of a 2-iodo-trifluoroacetanilide intermediate to build up the heterocyclic ring system. The N-Me substitution of the pyrrole ring enhanced the antitumor activity of the prepared molecules
    通过利用 Pd 催化的 domino Sonogashira 偶联/2-碘-三氟乙酰苯胺中间体的 5-endo-dig 环化来建立杂环系统,开发了一种从天然秋水仙碱开始的非外消旋吡咯-别秋水仙素的有效八步半合成方法。吡咯环的 N-Me 取代将制备的分子的抗肿瘤活性提高了 2-3 个数量级。在活性化合物中,N-甲基化秋水仙素在浓度 < 1 nm 时表现出强大的细胞毒性和抗增殖特性。
  • Synthesis and biological evaluation of novel non-racemic indole-containing allocolchicinoids
    作者:Ekaterina S. Shchegravina、Alexander A. Maleev、Stanislav K. Ignatov、Iuliia A. Gracheva、Andreas Stein、Hans-Günther Schmalz、Andrey E. Gavryushin、Anastasiya A. Zubareva、Elena V. Svirshchevskaya、Alexey Yu. Fedorov
    DOI:10.1016/j.ejmech.2017.09.055
    日期:2017.12
    Two novel indole-containing allocolchicinoids were prepared from naturally occurring coichicine exploiting the Curtius rearrangement and tandem Sonogashira coupling/Pd-catalyzed cyclization as the key transformations. Their cytotoxic properties, apoptosis-inducing activity, tubulin assembly inhibition and short-time cytotoxic effects were investigated. Compound 7 demonstrated the most pronounced anti-cancer activity: IC50 < 1 nM, cell cycle arrest in the G2/M phase, 25% apoptosis induction, as well as lower destructive short-time effects on HT-29 cell line in comparison with colchicine. Docking studies for prepared indole-derived allocolchicine analogues were carried out. (C) 2017 Elsevier Masson SAS. All rights reserved.
查看更多

同类化合物

别秋水仙碱 N-乙酰基秋水仙醇甲基醚 ANG 453; N-[(5S)-6,7-二氢-9,10,11-三甲氧基-3-(磷酰氧基)-5H-二苯并[a,c]环庚烯-5-基]乙酰胺 N-[(5S)-3-(2-tert-butoxycarbonylethylcarbamoyl)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[3-amino-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[3-((N-benzyloxycarbonylalanyl)amino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-(2-morpholinoethoxycarbonyl)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-(2-morpholinoethoxy)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-(1,2,3,9,10-pentamethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide N-(10-fuoro-9-hydroxy-1,2,3-trimethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl ethyl hydrogen phosphate N-[(5S)-3-phenoxycarbonyloxy-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl hydrogenmethylphosphonate 4-[([(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl]oxycarbonyl)amino]butanoic acid 4-[([(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl]aminocarbonyl)amino]butanoic acid 5-[{(5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl}oxycarbonyl]pentanoic acid N-[(5S)-3-(2,3-epoxypropoxy)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-(6-cyano-7-hydroxy-6-(ethoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)benzamide N-(6-cyano-7-hydroxy-6-(methoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)benzamide N-(6-cyano-3-fluoro-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulen-5-yl)benzamide ethyl 5-benzamido-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulene-6-carboxylate ethyl 5-benzamido-6-(ethoxymethyl)-7-hydroxy-6,7-dihydro-5H-dibenzo[a,c][7]annulene-6-carboxylate N-(6-cyano-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5H-dibenzo[a,c][7]annulen-5-yl)furan-2-carboxamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl hydrogensulphate N-[(5S)-3-(N,N-dimethylaminoacetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-9,10,11-trimethoxy-3-([(3-morpholinopropyl)amino]carbonylamino)-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide N-[(5S)-3-phenoxycarbonylamino-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-N-(3morpholinopropyl)-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-3-carboxamide (5S)-5-(acetylamino)-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-3-yl methyl carbonate N-((1S)-2''-(8-(metoxycarbonyl)octyl)-1',2',3'-trimetoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(pyridin-2-yl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(2-hydroxyethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(acetoxymethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-((diethylamino)methyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(1-hydroxycyclopentyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(hydroxymethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide N-((1S)-2''-(1-hydroxyethyl)-1',2',3'-trimethoxy-6,7-dihydro-1H-benzo[5',6':5,4]cyclohepta[3,2-f]benzofuran-1-yl)acetamide 1'-bromo-2',3',4'-trimethoxybenzo[5',6':4,5]-1H-(aR,1S)-1-acetamido-6,7-dihydrocyclohepta[3, 4-f]-1H-2-hydroxymethylindole 2-chloro-N-(6-cyano-7-hydroxy-6-(isopropoxymethyl)-6,7-dihydro-5Hdibenzo[a,c][7]annulen-5-yl)benzamide (R)-(+)-N-acetylolchinol 5-[N'-(3,5-difluorophenylacetyl)-L-alaninyl]amino-5,7-dihydro-6H-dibenzo[a,c]cyclohepten-6-ol N-(3,9,10,11-tetramethoxy-7-oxo-6,7-dihydro-5H-dibenzo [a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide (S)-7-acetamido-6,7-dihydro-1,2,3-trimethoxy-7H-dibenzocycloheptene N-(2-iodo-3,9,10,11-tetramethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide N-(9,10-dimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(9-hydroxy-1,2,3-trimethoxy-5,6-dihydro-7H-di-benzo[a,c][7]annulen-7-yl)acetamide N-(1,2,3,9-tetramethoxy-5,6-dihydro-7H-dibenzo[a,c][7]annulen-7-yl)acetamide N-(3-hydroxy-9,10-dimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(3-hydroxy-9,10,11-trimethoxy-7-oxo-6,7-dihydro-5H-dibenzo[a,c][7]cyclohepten-5-yl)-2,2,2-trifluoroacetamide N-(3-hydroxy-2-iodo-9,10,11-trimethoxy-6,7-dihydro-5H-dibenzo[a,c]cyclohepten-5-yl)-acetamide